Modelling future biomedical interventions in the COVID-19 epidemic

To date, intervention modelling in support of the COVID-19 public health response has focused on non-pharmaceutical interventions. With biomedical tools undergoing clinical trials, it is the moment to think ahead and assess how future interventions, based on these likely imperfect tools, could be used to control the COVID-19 epidemic and allow some de-escalation of current mitigation strategies. In this talk, we will discuss our preliminary work on antibody testing and vaccine interventions in a COVID-19 transmission model based on differential equations.